A recent spate of awards shines a light on the strides UTHSC researchers are making in translating their discoveries into novel solutions for human health and well-being. Three licensees, two spinoffs founded by UTHSC researchers and one long-standing partner, have received funding from the highly competitive Small Business Innovation Research (SBIR) and Small Business Technology… Read More
A team of UTHSC researchers has been awarded $924,000 from the Department of Defense for their work developing a new treatment for ovarian cancer. The project is a collaboration between the labs of Wei Li, PhD, distinguished professor of Pharmaceutical Sciences and director of the Drug Discovery Center in the College of Pharmacy, Junming Yue,… Read More
A research team at the University of Tennessee Health Science Center has been awarded $2.27 million to study a potential next-generation treatment for late-stage breast cancer. Wei Li, PhD, professor of Pharmaceutical Sciences and director of the UTHSC College of Pharmacy Drug Discovery Center, and Tiffany Seagroves, PhD, professor of Pathology in the UTHSC College… Read More
Nearly five years after beginning their research, investigators from the University of Tennessee Health Science Center, with collaboration from scientists at Oak Ridge National Laboratory (ORNL), have found what they believe will be a next generation treatment option for advanced prostate cancer. Clinical Cancer Research, a high-impact journal in the cancer field, published a paper on… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
